Approval · Notice of Compliance 3138 · 1998
NORVIR: Notice of Compliance 3138
Issued November 27, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3138
- Date
- November 27, 1998
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: provides for the treatment of pediatric patients, product monograph revisions
- Therapeutic class
- Human immunodeficiency virus (hiv) protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORVIR | Not yet assigned | — |